Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urokinase versus heparin catheter locks for non-tunneled central venous catheters
ChiCTR-IPR-14005524Phase 4Not yet recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Dec 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of urokinase and heparin (3 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoints: catheter related bloodstream infection, catheter function deficiency and 1 more. Planned start Dec 2014; status: not yet recruiting.
02
Drugs
urokinaseheparin
Beyond the preview
Go deeper on ChiCTR-IPR-14005524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005524.